| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000019167 |
| Receipt No. | R000022162 |
| Scientific Title | Functional and structural MRI study of mental disorders" |
| Date of disclosure of the study information | 2015/09/30 |
| Last modified on | 2022/04/13 (Ver. 7) |
| Basic information | ||
| Public title | Functional and structural MRI study of mental disorders"
|
|
| Acronym | MRI study | |
| Scientific Title | Functional and structural MRI study of mental disorders"
|
|
| Scientific Title:Acronym | MRI study | |
| Region |
|
|
| Condition | ||||
| Condition | Schizophrenia
Mood disorder Autism Demrntia |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | YES | |||
| Objectives | |
| Narrative objectives1 | Investigate relathinship between mental disorders and brain structure/function |
| Basic objectives2 | Others |
| Basic objectives -Others | Neuronal correlates of mental disorders |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Brain structure and function as measured by MRI |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The subjects with schizophrenia, mood disorder, dementia, neurodevelopmental disorders and their controls.
|
|||
| Key exclusion criteria | Those who are unable to give informed consent form, enter MRI scanner. Pregnant woman
|
|||
| Target sample size | ||||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya University | ||||||
| Division name | Graduate School of Medicine | ||||||
| Zip code | 466-8550 | ||||||
| Address | 65 Tsurumai, Showa, Nagoya, Aichi, Japan | ||||||
| TEL | 052-744-2282 | ||||||
| ozaki-n@med.nagoya-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya University | ||||||
| Division name | Graduate School of Medicine | ||||||
| Zip code | 466-8550 | ||||||
| Address | 65 Tsurumai, Showa, Nagoya, Aichi, Japan | ||||||
| TEL | 052-744-2282 | ||||||
| Homepage URL | |||||||
| ozaki-n@med.nagoya-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Strategic Research program for Brain Science |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nagoya University School of Medicine, Ethics Committee |
| Address | 65, Tsurumai, Showa, Nagoya, Aichi, Japan |
| Tel | 052-741-2111 |
| center-irb@med.nagoya-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Those who met our criteria have been used as the subjects in the experiment. Brain volumes, activation, and neuronal tract as measured by MRI have been compared bwteen the schizophreniac subject and normal controls.
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022162 |